Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose-control

Glucose-control is expected to reduce the incidence of bone fracture in type 2 diabetes mellitus patients, but the results are disappointed. Here, we found a therapeutic method that significantly improve the fragility of bone in T2DM mice.